MedTrace Logo

PHACE - Prospective Genetic Investigation

NCT05133245 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-12-23

No results posted yet for this study

Summary

Investigation for potential PHACE syndrome gene.

Conditions

  • PHACE Syndrome

Interventions

OTHER

Diagnostic study only

Diagnostic study only

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Karen Joos, MD, PhD · Vanderbilt Eye Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2026-11-01
Completion
2026-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05133245 on ClinicalTrials.gov